CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$3.11
+0.02 (+0.65%)
Open$3.08
Previous Close$3.09
Day High$3.17
Day Low$3.06
52W High$8.48
52W Low$1.03
Volume—
Avg Volume82.9K
Market Cap13.51M
P/E Ratio—
EPS$-1.18
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+600.0% upside
Current
$3.11
$3.11
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.83M | 2.61M | 1.11M |
| Net Income | -4,818,193 | -4,001,821 | -131,808 |
| Profit Margin | -170.1% | -161.6% | -11.8% |
| EBITDA | -4,992,832 | -4,377,252 | -161,572 |
| Free Cash Flow | — | — | -153,109 |
| Rev Growth | +8.4% | +8.4% | +14.6% |
| Debt/Equity | — | — | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |